Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-2 in Severe Alopecia Areata
NCT01840046Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Nov 2012
- Primary completion
- Nov 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in alopecia areata, sponsored by Centre Hospitalier Universitaire de Nice. Started Nov 2012; status: terminated.
02
Drugs
aldesleukin
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT01840046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01840046.